卡紐替尼抑制劑Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. Canertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
| 產品名稱： | 卡紐替尼 | ||
| 英文名： | Canertinib | ||
| CAS NO.： | 267243-28-7 | ||
| 分子式： | C23H23ClFN5O3 | ||
| 分子量： | 471.911827325821 | ||
| 產品品牌： | targetmol | ||
| 產品規格： | 5mg | ||
